Details for New Drug Application (NDA): 013400
✉ Email this page to a colleague
NDA 013400 describes ALDOMET, which is a drug marketed by Merck and is included in three NDAs. Additional details are available on the ALDOMET profile page.
The generic ingredient in ALDOMET is methyldopa. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methyldopa profile page.
The generic ingredient in ALDOMET is methyldopa. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methyldopa profile page.
Summary for 013400
| Tradename: | ALDOMET |
| Applicant: | Merck |
| Ingredient: | methyldopa |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 013400
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
